Table of Contents Author Guidelines Submit a Manuscript
Research Article

Capecitabine and Temozolomide (CAPTEM) in Neuroendocrine Tumor of Unknown Primary

Received 11 December 2017; Revised 12 March 2018; Accepted 29 March 2018

Academic Editor: Thomas E. Adrian